Priorities – Talk Bio

Actionable Insights Powered by AI

Johnson & Johnson Halts Phase II Dengue Study Amid Shift in R&D Priorities

Johnson & Johnson, Dengue Study, Phase II, Antiviral Drug, Mosnodenvir, Infectious Diseases, R&D Priorities